InforSense® Launches GenSense – Statistical Genetics Solution
LONDON & CAMBRIDGE, Mass.–(BUSINESS WIRE)–InforSense Ltd., the leading provider of enterprise real-time analytics, today announced the launch of InforSense GenSense, a statistical genetics solution built on the company’s flagship product – InforSense KDE.
“The data handling and analysis capabilities available through InforSense GenSense will significantly benefit the statistical genetics user community in their search for genetic effects on disease,” said Ross Lazarus, Director of Bioinformatics at the Channing Laboratory, Harvard. “I am particularly excited that functionality from our Rgenetics project is being made available through the GenSense offering; InforSense is the first commercial organization to do this.”
With the throughput that is possible from the new genotyping platforms, genetics is now well placed to deliver on the promise of delivering novel biomarkers. As whole genome association studies are becoming commonplace, analytics will be even more critical for delivering knowledge from these experiments.
At a recent Mayo Clinic Statistical Genetics Workshop chaired by Dr Jean-Pierre Kocher, Bioinformatics Core Director, the 100 attendees from industry and academia emphasized the need for a high throughput analytical platform for statistical genetics to help identify predictive and diagnostic biomarkers by analyzing associations between genotypic and phenotypic data. The conference was sponsored through an educational grant by InforSense.
“The InforSense KDE architecture, with its ability to incorporate the leading analysis techniques, flexibility in handling multiple data formats and ability to support streaming of very large data sets is ideally suited to provide the underlying platform on which to build GenSense,” said Jonathan Sheldon, Chief Science Officer, InforSense. “What we have heard from researchers worldwide indicates that our product is in sync with academia and industry needs.”
InforSense GenSense enables the analysis of data from the latest generation of genotyping platforms. It has been specifically designed to assist researchers understand complex analyses, quickly find interesting SNP’s and produce reports with easy to understand graphical summaries and interactive visualizations of large data sets. The first version of GenSense supports data from both Illumina and Affymetrix and supports links to standard genomics data sources such as Entrez Gene, HapMap and dbSNPs.
GenSense is currently available to partners under an early access program, with the general release scheduled for the first quarter of 2007. For more information on the early access program, contact Jonathan Sheldon at jsheldon@inforsense.com.
About InforSense KDE
Using InforSense KDE, enterprises rapidly integrate and deliver virtually any data source, analytic software tool, service or application within a single informatics framework. Users link these components via visual workflows to dynamically answer any question using their data, however complex or transient. Organizations can also mine their analytical processes to discover and deploy expertise and best practices. InforSense KDE provides an open, extensible service-oriented architecture, built using industry standards including J2EE, XML, and WSDL. InforSense IOE is a state-of–the-art solution for enterprise-wide integrative analytics using Oracle’s advanced information management and processing capabilities.
About InforSense
InforSense Ltd., the leader in integrative analytics, enables organizations to orchestrate and optimize their business-critical decision-making processes. Leading pharmaceutical, consumer goods, financial services companies, and research institutes are using the company’s flagship product, InforSense KDE, to enhance productivity across research and business analytics. The company is privately held, with European headquarters in London, UK and North American headquarters in Cambridge, Massachusetts.
For more information visit www.inforsense.com
InforSense, TextSense and the InforSense logo are registered trademarks of InforSense Limited. All rights reserved. All other trademarks mentioned in this document are the property of their respective owners.
